Persistently elevated levels of PTH (>800–1000 pg/mL in the absence of hypocalcemia) that fail to respond to a combination of calcimimetics and vitamin D analogues for more than 6–12 months are generally accepted as an indication for PTx [4,52]. The gene discussed is PTH; the disease is Hypocalcemia.